The Union Health Ministry of India has approved Corbevax as a heterologous COVID-19 booster dose under emergency use authorization for individuals aged 18 years.
With the global economic growth slowing, Morgan Stanley in its research report has revised India's GDP growth estimates to 7.2 percent in FY23 from 7.6 percent and 6.4 percent for FY24 from 6.7 percent.
EXAMIANS